author-photo

Deborah D. Brown

Merck & Co.

14

Papers

786

Citations

Citation Trend

Filter By

Papers (12) Sort By

Journal Conference Others

Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection

2020 Annals of Internal Medicine
Show All
- Source
- Cite
- Save
Citations (4)
Safety and tolerability of elbasvir/grazoprevir in chronic hepatitis C virus therapy: integrated analysis from clinical trials.

2020 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (1)
Efficacy and safety of elbasvir/grazoprevir for 8 or 12 weeks for hepatitis C virus: genotype 4 infection: a randomized study.

2019 Liver International
Show All
- Source
- Cite
- Save
Citations (6)
Final SVR24 Data From the Phase 3 C-Edge Treatment-Naïve Study of Elbasvir (EBR)/Grazoprevir (GZR) in Patients with Chronic HCV Genotype 1, 4 or 6 Infection

2016 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (1)
Safety and tolerability of elbasvir/grazoprevir in patients with chronic hepatitis C (HCV) infection: Integrated analysis of phase 2-3 trials

2016
Show All
- Source
- Cite
- Save
Citations (9)
Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 InfectionA Randomized TrialC-EDGE Treatment-Naive Trial of Grazoprevir–Elbasvir

2015 Annals of Internal Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic HCV Genotype 1, 4, or 6 Infection: A Randomized Trial

2015 Annals of Internal Medicine
Show All
- Source
- Cite
- Save
Citations (46)
Grazoprevir–Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial

2015 Annals of Internal Medicine
Show All
- Source
- Cite
- Save
Citations (432)
Long-Term Safety from the Raltegravir Clinical Development Program

2011 Current HIV Research
Show All
- Source
- Cite
- Save
Citations (34)
Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults

2008 Clinical Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (217)